Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CFTR | P13569 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | ASPH | Q12797 | 1/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL936925 | 0.81 | DAO (0.46) | DAOALDH1A1HPGDCES2NOTUM | |
| SCHEMBL27379121 | 0.80 | TAS2R14 (0.41) | DAOALDH1A1HPGDCES2CFTR | |
| SCHEMBL30755336 | 0.80 | TAS2R14 (0.41) | DAOALDH1A1HPGDCES2CFTR | |
| SCHEMBL19585173 | 0.79 | DAO (0.44) | DAOALDH1A1HPGDCES2NOTUM | |
| SCHEMBL30054183 | 0.78 | DAO (0.43) | DAOALDH1A1HPGDCES2NOTUM | |
| SCHEMBL6728532 | 0.78 | DPP4 (0.47) | DAOALDH1A1HPGDNOTUMKMO | |
| SCHEMBL1458478 | 0.78 | MEN1 (0.36) | DAOCES2CFTRNOTUMKMO | |
| SCHEMBL6725047 | 0.78 | DAO (0.43) | DAOALDH1A1HPGDCES2NOTUM | |
| SCHEMBL6418751 | 0.76 | CES2 (0.40) | ALDH1A1CES2ASPH | |
| SCHEMBL22980390 | 0.75 | DPP4 (0.47) | ALDH1A1HPGDNOTUMKMOASPH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6677479-B2 | REACTING A HALOGENATED BENZENE COMPOUND WITH ALDEHYDE; SOLVENT EXTRACTION; PURIFICATION | CLARIANT FINANCE LBVI LIMITED (VG) | 2004-01-13 | — | — | US | disclosed |
| US-20030092930-A1 | Substituted fluoroaromatics, process for preparing them and their use | CLARIANT GMBH | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092930-A1 | Substituted fluoroaromatics, process for preparing them and their use | CYP2F1, CYP1A1, CYP4X1 | DAO 681/4885ALDH1A1 589/4885HPGD 1275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.